Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Restructuring Costs (2025)

Rocket Pharmaceuticals' Restructuring Costs history spans 1 years, with the latest figure at -$68000.0 for Q4 2025.

  • For Q4 2025, Restructuring Costs changed N/A year-over-year to -$68000.0; the TTM value through Dec 2025 reached $3.1 million, changed N/A, while the annual FY2025 figure was $3.2 million, N/A changed from the prior year.
  • Restructuring Costs for Q4 2025 was -$68000.0 at Rocket Pharmaceuticals, down from $3.2 million in the prior quarter.
  • Across five years, Restructuring Costs topped out at $3.2 million in Q2 2025 and bottomed at -$68000.0 in Q4 2025.